Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Stephen Safe
Activation of Genes by Nuclear Receptor/Specificity Protein (Sp) Interactions in Cancer
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Emerging Anti-Cancer Compounds and Immunomodulators for Pan" by Kathleen E DelGiorno, Stephen Safe et al.
To view the content in your browser, please download Adobe Reader or, alternately, you may Download the file to your hard drive. NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.
Specificity Proteins (Sp) and Cancer
Abstract : The specificity protein (Sp) transcription factors (TFs) Sp1, Sp2, Sp3 and Sp4 exhibit structural and functional similarities in cancer cells and extensive studies of Sp1 show that it is a negative prognostic factor for patients with multiple tumor types. In this review, the role of Sp1, Sp3 and Sp4 in the development of cancer and their regulation of pro-oncogenic factors and pathways is reviewed.
Aryl Hydrocarbon Receptor (AhR) Signaling in Colonic Cells and Tumors
Altmetric share Share announcement Help format_quote Cite thumb_up ... Endorse textsms ... Comment Need Help? Support Find support for a specific problem in the support section of our website. Get Support Feedback Please let us know what you think of our products and services. Give Feedback Information Visit our dedicated information section to learn more about MDPI.
Health Benefits of Coffee Consumption for Cancer and Other Diseases and Mechanisms of Action
This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessReview by Stephen Safe 1,*, Jainish Kothari 2, Amanuel Hailemariam 1, Srijana Upadhyay 1, Laurie A. Davidson 3 and Robert S.
Cigarette Smoking and Estrogen-Related Cancer-Reply
Letters to the Editor John A. Baron, Hazel B. Nichols and Stephen Safe DOI: 10.1158/1055-9965.EPI-21-0794 Published October 2021 This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below. Log in using your username and password Username * Password * Forgot your user name or password? Purchase access You may purchase access to this article.
Cigarette Smoking and Estrogen-Related Cancer
Review John A. Baron, Hazel B. Nichols, Chelsea Anderson and Stephen Safe DOI: 10.1158/1055-9965.EPI-20-1803 Published August 2021 This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Cigarette Smoking and Estrogen-Related Cancer
Review John A. Baron, Hazel B. Nichols, Chelsea Anderson and Stephen Safe DOI: 10.1158/1055-9965.EPI-20-1803 Abstract Cigarette smoking is a known cause of many cancers, yet epidemiologic studies have found protective associations with the risk of four “estrogen-related” malignancies: endometrial cancer, endometrioid and clear cell ovarian cancers, and thyroid cancer.
Cigarette Smoking and Estrogen-Related Cancer
Review John A. Baron, Hazel B. Nichols, Chelsea Anderson and Stephen Safe DOI: 10.1158/1055-9965.EPI-20-1803 Abstract Cigarette smoking is a known cause of many cancers, yet epidemiological studies have found protective associations with the risk of four "estrogen-related" malignancies: endometrial cancer, endometrioid and clear cell ovarian cancers, and thyroid cancer.
The Paradoxical Roles of Orphan Nuclear Receptor 4A (NR4A) in Cancer
Reviews Stephen Safe and Keshav Karki DOI: 10.1158/1541-7786.MCR-20-0707 Published February 2021 This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways
17?-Estradiol binds to the estrogen receptor (ER) to activate gene expression or repression and this involves both genomic (nuclear) and non-genomic (extranuclear) pathways. Genomic pathways include the classical interactions of ligand-bound ER dimers with estrogen-responsive elements in target gene promoters.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Stephen
Contact Stephen, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack